Akili, the company behind a video game-like prescription digital therapeutic for children with ADHD, reported a rise in third-quarter revenue to $702,000, from $114,000 in the second quarter of this year, which the company attributes to the continued growth of its adult ADHD offering EndeavorOTC.
The company reported total operating expenses of $18.8 million for the third quarter, compared to $15...
Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test.
The Cue COVID-19 Molecular Test detects genetic material from the SARS-CoV-2 virus. It consists of a nasal swab, or Cue Sample Wand, and a Cue Cartridge Reader. After taking the test, adults with respiratory infection symptoms receive the...
Cue Health laid off another 326 workers, or about 30% of the home diagnostics company's workforce, as part of a new cost reduction plan.
The cuts mark a second round of layoffs this year. In January, Cue laid off 388 employees, about 26% of its workforce.
In a filing with the Securities and Exchange Commission, Cue said it had approved the new plan at the end of last month, aiming to "reduce the...
Cue Health will lay off 388 employees, about 26% of its workforce, as part of a larger cost-reduction plan.
The cuts mark another round of layoffs for the home diagnostics company, which laid off 170 manufacturing workers in the summer. In a filing with the Securities and Exchange Commission, Cue said the layoffs are expected to take place in March.
"For the past several months, the Cue Health...
Morgan Health, JPMorgan Chase's healthcare business unit, announced that Dr. Cheryl Pegus will support the company's strategic investments aimed at closing gaps in healthcare, working closely with Dan Hartman and Jeff Reis, who lead the company's ventures and investment efforts.
Pegus previously served as executive vice president for health and wellness at Walmart, where she helped launch...
Babylon announced Thursday the digital health firm had hired Andrew Hine as vice president of the go-to-market team for Asia, Europe, the Middle East and Africa.
The company said he'll manage Babylon's contracts and partnerships and work to increase its offerings and services in those regions. Hine joins Babylon from Ernst & Young, where he was head of health for the Middle East and North...
Less than a year after it went public, diagnostics company Cue Health has laid off 170 manufacturing workers.
First reported by STAT, Cue said the layoffs reflected larger economic conditions, as well as the federal government's recent move to divert funding from COVID-19 testing to secure vaccines and treatments.
The diagnostics company is best known for its at-home molecular COVID-19 test,...
Digital chronic condition management company DarioHealth posted a net loss of $15.9 million in the first quarter, slightly higher than the $15 million net loss from Q1 last year. But the company beat its revenue expectations with $8.06 million, a 124% increase from last year.
Total operating expenses were $19.9 million, compared with $15.4 million in Q1 2021 and $22.2 million during the fourth...
Diagnostic company Cue Health announced on Thursday that it will create an Omicron-genotyping COVID-19 test.
The test will be used in professional care settings to specifically detect the Omicron variant in nasal samples. The work is part of a partnership with HHS’ Biomedical Advanced Research and Development Authority (BARDA).
"An Omicron-specific test will assist clinicians in providing...
Though COVID-19 vaccines began their rollout to the public, 2021 was still a turbulent year for healthcare providers as they weathered new virus variants, staffing shortages and burnout.
But the pandemic also created a new wave of interest in virtual care and telehealth. Many providers turned toward the modality to keep in contact with patients in 2020, but startups and other organizations are...
